PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $312,000 | -88.2% | 99,400 | -86.0% | 0.00% | -87.5% |
| Q1 2019 | $2,640,000 | +18.3% | 709,800 | -7.7% | 0.02% | +20.0% |
| Q4 2018 | $2,231,000 | -27.0% | 769,400 | -33.8% | 0.02% | -13.0% |
| Q3 2018 | $3,056,000 | +41.7% | 1,161,800 | +26.0% | 0.02% | +27.8% |
| Q2 2018 | $2,157,000 | -10.1% | 921,700 | +12.9% | 0.02% | -21.7% |
| Q1 2018 | $2,400,000 | +2.1% | 816,200 | -4.9% | 0.02% | +15.0% |
| Q4 2017 | $2,351,000 | -44.9% | 858,000 | -31.9% | 0.02% | -48.7% |
| Q3 2017 | $4,269,000 | +47.6% | 1,259,300 | +7.5% | 0.04% | +39.3% |
| Q2 2017 | $2,892,000 | -60.3% | 1,170,900 | -63.5% | 0.03% | -17.6% |
| Q1 2017 | $7,276,000 | +102.2% | 3,205,200 | +88.9% | 0.03% | -20.9% |
| Q4 2016 | $3,598,000 | -29.3% | 1,697,000 | +11.7% | 0.04% | -21.8% |
| Q3 2016 | $5,090,000 | +18.9% | 1,519,400 | +11.4% | 0.06% | +14.6% |
| Q2 2016 | $4,281,000 | +5.2% | 1,363,400 | +11.5% | 0.05% | +4.3% |
| Q1 2016 | $4,071,000 | -26.0% | 1,222,500 | -21.4% | 0.05% | -35.2% |
| Q4 2015 | $5,503,000 | – | 1,554,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |